Column Group LLC Tenaya Therapeutics, Inc. Transaction History
Column Group LLC
- $79.2 Million
- Q3 2025
A detailed history of Column Group LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Column Group LLC holds 9,400,290 shares of TNYA stock, worth $12.8 Million. This represents 18.17% of its overall portfolio holdings.
Number of Shares
9,400,290
Previous 9,400,290
-0.0%
Holding current value
$12.8 Million
Previous $5.73 Million
150.82%
% of portfolio
18.17%
Previous 8.73%
Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
98Shares Held
38.2MCall Options Held
313KPut Options Held
61.1K-
Vanguard Group Inc Valley Forge, PA5.06MShares$6.89 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.5MShares$6.13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$5.54 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.68MShares$2.28 Million0.0% of portfolio
-
Ghost Tree Capital, LLC New York, NY1.5MShares$2.04 Million1.08% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $56.3M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...